BioAffinity Interest Expense from 2010 to 2025

BIAFW Stock  USD 0.60  0.01  1.64%   
BioAffinity Technologies Interest Expense yearly trend continues to be fairly stable with very little volatility. Interest Expense will likely drop to about 40.6 K in 2025. Interest Expense is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. View All Fundamentals
 
Interest Expense  
First Reported
2010-12-31
Previous Quarter
42.7 K
Current Value
40.6 K
Quarterly Volatility
613.1 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BioAffinity Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioAffinity Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 301.4 K, Interest Expense of 40.6 K or Gross Profit of 955.9 K, as well as many indicators such as Price To Sales Ratio of 5.55, Dividend Yield of 0.0 or PTB Ratio of 2.5. BioAffinity financial statements analysis is a perfect complement when working with BioAffinity Technologies Valuation or Volatility modules.
  
Check out the analysis of BioAffinity Technologies Correlation against competitors.

Latest BioAffinity Technologies' Interest Expense Growth Pattern

Below is the plot of the Interest Expense of bioAffinity Technologies Warrant over the last few years. It is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. BioAffinity Technologies' Interest Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioAffinity Technologies' overall financial position and show how it may be relating to other accounts over time.
Interest Expense10 Years Trend
Pretty Stable
   Interest Expense   
       Timeline  

BioAffinity Interest Expense Regression Statistics

Arithmetic Mean386,586
Geometric Mean208,803
Coefficient Of Variation158.61
Mean Deviation345,165
Median214,834
Standard Deviation613,146
Sample Variance375.9B
Range2.5M
R-Value0.23
Mean Square Error380.9B
R-Squared0.05
Significance0.39
Slope29,999
Total Sum of Squares5.6T

BioAffinity Interest Expense History

202540.6 K
202442.7 K
202337.1 K
20222.5 M
2021M
2020382.2 K

About BioAffinity Technologies Financial Statements

BioAffinity Technologies investors use historical fundamental indicators, such as BioAffinity Technologies' Interest Expense, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioAffinity Technologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Interest Expense42.7 K40.6 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioAffinity Stock Analysis

When running BioAffinity Technologies' price analysis, check to measure BioAffinity Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies is operating at the current time. Most of BioAffinity Technologies' value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies' price. Additionally, you may evaluate how the addition of BioAffinity Technologies to your portfolios can decrease your overall portfolio volatility.